HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 75 filers reported holding HOOKIPA PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,372 | -1.3% | 110,993 | +40.9% | 0.00% | – |
Q2 2023 | $69,304 | +19.6% | 78,754 | 0.0% | 0.00% | – |
Q1 2023 | $57,963 | -10.7% | 78,754 | -1.7% | 0.00% | – |
Q4 2022 | $64,880 | -39.9% | 80,099 | -1.0% | 0.00% | – |
Q3 2022 | $108,000 | +13.7% | 80,908 | +38.2% | 0.00% | – |
Q2 2022 | $95,000 | -74.7% | 58,529 | -64.5% | 0.00% | – |
Q1 2022 | $376,000 | -6.7% | 164,799 | -4.7% | 0.00% | – |
Q4 2021 | $403,000 | -61.0% | 172,955 | -1.4% | 0.00% | – |
Q3 2021 | $1,033,000 | -48.3% | 175,479 | -19.6% | 0.00% | – |
Q2 2021 | $1,997,000 | -9.8% | 218,134 | +32.6% | 0.00% | – |
Q1 2021 | $2,213,000 | +33.3% | 164,542 | +9.9% | 0.00% | – |
Q4 2020 | $1,660,000 | +23.1% | 149,730 | +5.1% | 0.00% | – |
Q3 2020 | $1,349,000 | -17.6% | 142,459 | +1.0% | 0.00% | – |
Q2 2020 | $1,638,000 | +68.9% | 141,029 | +19.9% | 0.00% | – |
Q1 2020 | $970,000 | -8.1% | 117,635 | +36.2% | 0.00% | – |
Q4 2019 | $1,056,000 | +208.8% | 86,350 | +89.6% | 0.00% | – |
Q3 2019 | $342,000 | +375.0% | 45,552 | +328.0% | 0.00% | – |
Q2 2019 | $72,000 | – | 10,642 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 530,245 | $3,569,000 | 2.36% |
Redmile Group, LLC | 1,891,879 | $12,732,000 | 0.36% |
Artal Group S.A. | 1,134,616 | $7,636,000 | 0.31% |
DC Investments Management, LLC | 42,857 | $288,000 | 0.16% |
Hillhouse Capital Management | 657,540 | $4,425,000 | 0.14% |
HHLR ADVISORS, LTD. | 285,714 | $1,923,000 | 0.04% |
Baker Brothers Advisors | 892,857 | $6,009,000 | 0.04% |
Tower Research Capital LLC (TRC) | 6,011 | $40,000 | 0.00% |
Artisan Partners Limited Partnership | 126,273 | $850,000 | 0.00% |
SALEM INVESTMENT COUNSELORS INC | 900 | $6,000 | 0.00% |